Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2018 Filed Mar 15, 2018 01:04 UTC |
Powers Linda FDirector · President and CEO
|
OtherClass D-1 Warrants · Derivative | 29,411,760 | Not disclosed Strike: $0.22 | Not disclosed |
DisclosureSEC source: 0001144204-18-014763 · tv488530_4.xml · derivative · entry 5 Powers Linda F · CIK 0001289624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,411,760 Underlying: Common Stock · 29,411,760 shares Expires not disclosed F2 · kind: The reported transactions are exempt from Section 16(b) of the Exchange Act because the securities were received by the reporting person as payment of $5 million of debt previously contracted and owed by a third party to the reporting person (which was part of a larger debt previously contracted by the third party to the reporting person which was unpaid) as the third party was unable to make any repayment in cash. F4 · price: A $5 million portion of a larger pre-existing debt owed by a third party to the reporting person was paid by assignment of this Series A Preferred Stock and Class D-1 Warrants to the reporting person as the third party was unable to make any repayment in cash. F3 · derivative.exercise_date: Convertible and exercisable when the Company has sufficient shares of common stock authorized and available. The Class D-1 Warrants are not currently exercisable and will expire two years after they become exercisable. F3 · derivative.expiration_date: Convertible and exercisable when the Company has sufficient shares of common stock authorized and available. The Class D-1 Warrants are not currently exercisable and will expire two years after they become exercisable. Read SEC document |
| March 12, 2018 Filed Mar 15, 2018 01:04 UTC |
Powers Linda FDirector · President and CEO
|
OtherSeries A Preferred Stock · Derivative | 2,941,176 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001144204-18-014763 · tv488530_4.xml · derivative · entry 4 Powers Linda F · CIK 0001289624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,941,176 Underlying: Common Stock · 29,411,760 shares Expires not disclosed F2 · kind: The reported transactions are exempt from Section 16(b) of the Exchange Act because the securities were received by the reporting person as payment of $5 million of debt previously contracted and owed by a third party to the reporting person (which was part of a larger debt previously contracted by the third party to the reporting person which was unpaid) as the third party was unable to make any repayment in cash. F4 · price: A $5 million portion of a larger pre-existing debt owed by a third party to the reporting person was paid by assignment of this Series A Preferred Stock and Class D-1 Warrants to the reporting person as the third party was unable to make any repayment in cash. F3 · derivative.exercise_date: Convertible and exercisable when the Company has sufficient shares of common stock authorized and available. The Class D-1 Warrants are not currently exercisable and will expire two years after they become exercisable. F3 · derivative.expiration_date: Convertible and exercisable when the Company has sufficient shares of common stock authorized and available. The Class D-1 Warrants are not currently exercisable and will expire two years after they become exercisable. Read SEC document |
| June 13, 2017 Filed Jun 16, 2017 01:25 UTC |
BOYNTON ALTON LDirector · Chief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,402,935 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001144204-17-032807 · v469119_4.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,402,935 Underlying: Common Stock · 3,402,935 shares Expires 2022-06-13 F1 · derivative.exercise_date: The option's vesting schedule is as follows: 50% vested upon the date of grant with the remaining 50% vesting over a 24-month period in equal monthly installments Read SEC document |
| June 13, 2017 Filed Jun 29, 2017 20:25 UTC |
BOSCH MARNIX LChief Technical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,940,182 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001144204-17-034899 · v469635_4.xml · derivative · entry 1 BOSCH MARNIX L · CIK 0001253933 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,940,182 Underlying: Common Stock · 7,940,182 shares Expires 2022-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option's vesting schedule is as follows: 50% vested upon the date of grant with the remaining 50% vesting over a 24-month period in equal monthly installments Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.